OBJECTIVES: Due to the global economic crisis, most of the actions of the Hungarian government are focused on cost reductions, including in the health care sector. According to the ownership structure’s changes (i.e., the state becoming the owner), the most important thing is to create a well-monitored and centralized hospital system. In addition to these changes, the government seeks to centralize the procurement of pharmaceuticals and medical equipment at state-owned hospitals.  METHODS: We have prepared literature review and interviews with high level hospital and political leaders to find how can we strengthen the regulation of drug consumption at hospitals, which is at this time without strict controls. RESULTS: Due to the specific objectives of the HunDRG system, which are focused more on monitoring the number of DRG cases than tracking resources, there are no incentives for hospitals to maintain strict inventories of their drugs. Except for biological drugs, which use an itemized financing system, there is no pressure by the government to monitor the medical costs at the unit level; as such, only hospital data exists. Based on IMS data in 2011, the total hospital sector was valued at approximately 100 billion HUF. Most of the hospitals do not have adequate computer systems to monitor the patient-level data.  CONCLUSIONS: In conclusion, the so called unit-dose system could be a good solution to measure the drug consumption at the patient level and to improve drug security (trial system). To sum up, it is very important to gain more data regarding the Hungarian hospital system to be able to create a sustainable, transparent, highly-regulated, and centralized public health care system.